KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Stryker (SYK) Research & Development (2016 - 2026)

Stryker has reported Research & Development over the past 18 years, most recently at $413.0 million for Q1 2026.

  • Quarterly Research & Development rose 1.98% to $413.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.6 billion through Mar 2026, up 8.52% year-over-year, with the annual reading at $1.6 billion for FY2025, 10.71% up from the prior year.
  • Research & Development was $413.0 million for Q1 2026 at Stryker, up from $401.0 million in the prior quarter.
  • Over five years, Research & Development peaked at $413.0 million in Q1 2022 and troughed at $326.0 million in Q4 2022.
  • The 5-year median for Research & Development is $364.0 million (2022), against an average of $373.2 million.
  • Year-over-year, Research & Development surged 43.4% in 2022 and then dropped 17.92% in 2023.
  • A 5-year view of Research & Development shows it stood at $326.0 million in 2022, then rose by 7.36% to $350.0 million in 2023, then increased by 2.29% to $358.0 million in 2024, then grew by 12.01% to $401.0 million in 2025, then grew by 2.99% to $413.0 million in 2026.
  • Per Business Quant, the three most recent readings for SYK's Research & Development are $413.0 million (Q1 2026), $401.0 million (Q4 2025), and $410.0 million (Q3 2025).